MAPT and Alzheimer disease: We find higher levels in AD of hippocampal aggregates that bind antibody against Aβ1–42 or tau; these immuno‐purified conglomerates contain many proteins that differ markedly and reproducibly in quantity and post‐translational modifications between AD and normal controls.